Vectors for cardiovascular gene therapy

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 7, 2003, Pages 731-733

  Rosenzweig, Anthony ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GENE PRODUCT; LENTIVIRUS VECTOR; NAKED DNA; PLASMID DNA; RECOMBINANT DNA; RETROVIRUS VECTOR;

ARTERY INTIMA; BIOSAFETY; CARDIOVASCULAR SYSTEM; CELL DIVISION; CELLULAR IMMUNITY; CHROMOSOME; COMBINED IMMUNODEFICIENCY; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC CODE; IMMUNE RESPONSE; IN VIVO STUDY; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; TISSUE SPECIFICITY; TRANSGENE; VIRUS GENE;

ADENOVIRIDAE; LENTIVIRUS; PARVOVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0037785371     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00144-5     Document Type: Editorial

References (40)

1. Journal of Gene Medicine. 2003 Web site.
2. Rosenzweig A, guest section editor. Vectors for gene delivery in current protocols in human genetics. New York: NY: John Wiley & Sons; 2001.
3. Lin H., Parmacek M.S., Morle G., Bolling S., Leiden J.M. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 82:1990;2217-2221.
4. Kitsis R.N., Buttrick P.M., McNally E.M., Kaplan M.L., Leinwand L.A. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA. 88:1991;4138-4142.
5. Gal D., Weir L., Leclerc G., Pickering J.G., Hogan J., Isner J.M. Direct myocardial transfection in two animal models. Evaluation of parameters affecting gene expression and percutaneous gene delivery. Lab Invest. 68:1993;18-25.
6. Wright M.J., Wightman L.M., Lilley C., de Alwis M., Hart S.L., Miller A., et al. In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol. 96:2001;227-236.
7. Takeshita S., Rossow S.T., Kearney M., Zheng L.P., Bauters C., Bunting S., et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 147:1995;1649-1660.
8. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 98:1998;2800-2804.
9. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 73:1993;1202-1207.
10. Barr E., Carroll J., Kalynych A.M., Tripathy S.K., Kozarsky K., Wilson J.M., et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:1994;51-58.
11. Hajjar R.J., Schmidt U., Matsui T., Guerrero J.L., Lee K.H., Gwathmey J.K., et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA. 95:1998;5251-5256.
12. Lemarchand P., Jones M., Yamada I., Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 72:1993;1132-1138.
13. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation. 88:1993;2838-2848.
14. Lee S.W., Trapnell B.C., Rade J.J., Virmani R., Dichek D.A. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 73:1993;797-807.
15. Schulick A.H., Dong G., Newman K.D., Virmani R., Dichek D.A. Endothelium-specific in vivo gene transfer. Circ Res. 77:1995;475-485.
16. Schulick A.H., Newman K.D., Virmani R., Dichek D.A. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation. 91:1995;2407-2414.
17. Newman K.D., Dunn P.F., Owens J.W., Schulick A.H., Virmani R., Sukhova G., et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 96:1995;2955-2965.
18. Schneider D.B., Fly C.A., Dichek D.A., Geary R.L. Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. Hum Gene Ther. 9:1998;815-821.
19. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 286:1999;2244-2245.
20. Prasad S.A., Norbury C.C., Chen W., Bennink J.R., Yewdell J.W. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J Immunol. 166:2001;4809-4812.
21. Engelhardt J.F., Ye X., Doranz B., Wilson J.M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 91:1994;6196-6200.
22. Kochanek S., Clemens P.R., Mitani K., Chen H.H., Chan S., Caskey C.T. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci USA. 93:1996;5731-5736.
23. Wen S., Driscoll R.M., Schneider D.B., Dichek D.A. Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer. Arterioscler Thromb Vasc Biol. 21:2001;1777-1782.
24. Svensson E.C., Marshall D.J., Woodard K., Lin H., Jiang F., Chu L., et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation. 99:1999;201-205.
25. Ye X., Rivera V.M., Zoltick P., Cerasoli F. Jr, Schnell M.A., Gao G., et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science. 283:1999;88-91.
26. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 105:2002;602-607.
27. Hoshijima M., Ikeda Y., Iwanaga Y., Minamisawa S., Date M.O., Gu Y., et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat M. 8:2002;864-871.
28. Check E. Second cancer case halts gene-therapy trials. Nature. 421:2003;305.
29. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J M. 348:2003;255-256.
30. Xiao X., Li J., Samulski R.J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 72:1998;2224-2232.
31. Clark K.R., Voulgaropoulou F., Fraley D.M., Johnson P.R. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther. 6:1995;1329-1341.
32. Liu X.L., Clark K.R., Johnson P.R. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther. 6:1999;293-299.
33. Dishart KL, Denby L, George SJ, Nicklin SA, Yendluri S, Tuerk MJ, et al. Third-generation lentivrus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J Mol Cell Cardiol 2003;35:739-48, in this issue.
34. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
35. Naldini L., Blomer U., Gage F.H., Trono D., Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA. 93:1996;11382-11388.
36. Sakoda T., Kasahara N., Hamamori Y., Kedes L. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol. 31:1999;2037-2047.
37. Peng K.W., Pham L., Ye H., Zufferey R., Trono D., Cosset F.L., et al. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8:2001;1456-1463.
38. MacKenzie T.C., Kobinger G.P., Kootstra N.A., Radu A., Sena-Esteves M., Bouchard S., et al. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther. 6:2002;349-358.
39. Zhao J., Pettigrew G.J., Thomas J., Vandenberg J.I., Delriviere L., Bolton E.M., et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol. 97:2002;348-358.
40. Klages N., Zufferey R., Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther. 2:2000;170-176.